2025 Shanghai CPHI: Building the Future of Medicine in the Name of Technology

2025 Shanghai CPHI: Building the Future of Medicine in the Name of Technology
National Exhibition and Convention Center (Shanghai), June 24-26, 2025

After three days of intellectual exchanges and in-depth industry exploration, the 2025 Shanghai CPHI World Pharmaceutical Raw Materials Exhibition came to a successful conclusion on June 26th. As a barometer of the global pharmaceutical industry, this exhibition has brought together many top enterprises in the field of pharmaceutical raw materials. We made a stunning appearance with innovative laboratory solutions such as fully automatic melting point testers, fully automatic density testers, and precision refractometers (booth No. : W12B18), showcasing the hard-core strength of "Made in China" to the world!
Booth grandeur: Empowered by technology, it ignites professional attention
Dynamic demonstration area: The fully automatic melting point apparatus can complete drug purity detection with one click. With a temperature accuracy of 0.1℃ and AI spectrum analysis technology, it has received on-site inquiries from most enterprises.
Negotiation Zone: Place orders for products on-site with customers. The digital report output function has been highly recognized by the FDA-compliant laboratory.
Technical Prowess: Cracking the Core Demands of Pharmaceutical Quality Control
Fully automatic melting point apparatus
▶ Temperature control range: Room temperature -400℃; Accuracy: ±0.1℃
"▶ In line with
Fully automatic density meter
▶ 5-second rapid measurement: Built-in Peltier temperature control (10-40℃±0.01℃)
▶ Automatic cleaning and drying technology
Family of intelligent refractometers
▶ Wavelength: 589nm sodium light source; Prism: sapphire
One-click switch between sugar content, Brix and API concentration
Thank you for the encounter. The future is here
We would like to express our sincere gratitude to every partner who visited booth W12B18 in person!
Your professional insights have made us deeply feel that
✅ Precision - the strict demand for data traceability in drug development;
✅ Automation - the urgent expectation of QC laboratories for optimizing labor costs;
✅ Compliance - a wave of technological upgrades driven by the iteration of global pharmacopoeia standards.